The global fight against AMR and infections
Antibiotic and antimicrobial resistance (AMR) is a global societal challenge and public health issue that threatens sustainable development and our modern healthcare. Often mentioned as “the silent pandemic”, it must be on top of the international political agenda. AMR causes 33,000 deaths annually in Europe and 700,000 globally, a figure that is expected to increase to 10 million by 2050.
Health care-associated infections are the most frequent adverse event in healthcare delivery worldwide and a significant cause of illness and death, especially in the absence of effective antibiotics. Hundreds of millions of patients are affected by health care-associated infections worldwide each year, leading to significant financial losses for health systems. In high-income countries, approximately 30% of patients in intensive care units are affected by at least one healthcare-associated infection, with the frequency in low- and middle-income countries estimated to be at least 2─3 fold higher than in high-income countries.
1 in 10
patients get a healthcare associated infection while receiving care.
Up to 32%
of surgical patients get a post-operative infection.
of all countries have implemented a national policy to tackle AMR.
Less than 40% of countries have put in place infection prevention and control programmes for AMR.
increased the Antibiotic consumption of human health globally between 2000 and 2010.
of patients with colds receive antibiotics inappropriately. Antibiotics have no effect at all on colds.